DUKE HUMAN VACCINE INSTITUTE
The Duke Human Vaccine Institute develops vaccines and therapeutics against diseases of global importance.The investigators at the DHVI conduct basic and translational research to develop novel vaccines, therapeutics and diagnostics for diseases
DUKE HUMAN VACCINE INSTITUTE
Industry:
Biotechnology Health Care Health Diagnostics Medical
Founded:
1986-01-01
Address:
Durham, North Carolina, United States
Country:
United States
Website Url:
http://www.dhvi.duke.edu
Total Employee:
251+
Status:
Active
Contact:
919-684-5384
Email Addresses:
[email protected]
Total Funding:
17.5 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Analytics Google Tag Manager Content Delivery Network Google Universal Analytics Font Awesome Apache Global Site Tag JsDelivr
Similar Organizations
Advanced Cell Diagnostics
Advanced Cell Diagnostics is a molecular pathology company developing cell- and tissue-based diagnostic tests for personalized medicine.
Current Employees Featured
Investors List
National Institute of Allergy and Infectious Diseases
National Institute of Allergy and Infectious Diseases investment in Grant - Duke Human Vaccine Institute
Official Site Inspections
http://www.dhvi.duke.edu
- Host name: dcvu.dhvi.duke.edu
- IP address: 152.16.0.235
- Location: Durham United States
- Latitude: 35.9968
- Longitude: -78.8955
- Metro Code: 560
- Timezone: America/New_York
- Postal: 27701
More informations about "Duke Human Vaccine Institute"
Careers | Duke Human Vaccine Institute - Duke University
DHVI's postdoctoral researcher Ashley Bennett (Henderson Lab) describes an HIV discovery they hope will bring a vaccine across the finish line. Watch our videos to learn more about DHVI’s various research areas, our state-of-the-art …See details»
About Us | Duke Human Vaccine Institute - Duke …
The Duke Human Vaccine Institute continues to lead with cutting edge vaccine research against infectious diseases that impact global health. The investigators at DHVI conduct basic and translational research to develop novel vaccines, …See details»
Duke University Human Vaccine Institute - Wikipedia
The Duke Human Vaccine Institute (DHVI), located in Durham, North Carolina, was formed to support Duke University School of Medicine's efforts to develop vaccines and therapeutics for HIV and other emerging infections. The vaccine strategy of the Duke CHAVI-ID is based on identifying and targeting novel HIV-1 vulnerabilities to B, T, and NK cell immune responses and using this information to design vaccines that will induce protective immunity at the time and location of HI…See details»
The Duke Human Vaccine Institute - LinkedIn
If you have a background in biology, strong lab skills, and two years of research experience, visit dhvi.duke.edu/careers and apply today! #WorkAtDuke #ProgramManagement #ScienceJobs …See details»
Duke Awarded Federal Grant to Build Structural Models of HIV
Jun 28, 2022 DURHAM, N.C. – Researchers at the Duke Human Vaccine Institute (DHVI) received a federal grant totaling more than $27 million over five years to focus on building …See details»
Years in the Making: Duke Human Vaccine Institute …
Nov 3, 2020 DHVI enrolled more than 80 volunteers for the Phase 2/3 trial of the Pfizer vaccine candidate. Photo by Lindsay Key. Mary-Russell Roberson is a freelance writer in Durham. She covers the geriatrics and aging beat for the …See details»
Duke Institute Lands Federal Contract to Make Vaccine …
Dec 14, 2021 DURHAM, N.C. – The National Institute of Allergy and Infectious Diseases awarded researchers at the Duke Human Vaccine Institute a contract that enables it to compete for projects advancing investigational vaccines to …See details»
Accessioning Unit Core | Duke Human Vaccine Institute - Duke …
The Duke Human Vaccine Institute (DHVI) Accessioning Unit and Biorepository (AUB) became an American Association of Laboratory Accreditation (A2LA) accredited biobank under the …See details»
GPS-like System Shows Promise as HIV Vaccine …
DURHAM, N.C. – A team led by the Duke Human Vaccine Institute (DHVI) has developed a vaccine approach that works like a GPS, guiding the immune system through the specific steps to make broadly neutralizing antibodies against …See details»
Emmanuel “Chip” Walter Jr. - Duke Global Health …
Contact. [email protected] (919) 620-5346. Duke Vaccine and Trials Unit-RTP, Duke University PO Box 106008, Durham, NC 27710-6008. View WebsiteSee details»
History | Duke Human Vaccine Institute - Duke University
Sep 4, 2024 Since 1990, DHVI investigators have been at the forefront in the battle against AIDS and specifically in the quest for an HIV vaccine. Today, The Duke Human Vaccine …See details»
Duke Institute Awarded $129 Million Grant in Ongoing Quest for …
Jul 10, 2019 The Duke Human Vaccine Institute (DHVI) will remain at the lead of the nation’s effort to develop an HIV vaccine, receiving a third, seven-year grant from the National Institute …See details»
Duke Human Vaccine Institute Wins Contract to Produce Pan
Jan 31, 2023 The DHVI published results in May 2021 and October 2022 showing proof-of-concept in preclinical studies for this potential three-dose vaccine. Under the new NIH …See details»
Duke Awarded Federal Grant to Build Structural Models of HIV
Jun 28, 2022 Researchers at the Duke Human Vaccine Institute (DHVI) received a federal grant totaling more than $27 million over five years to focus on building structural models of HIV that …See details»
Duke Researchers among Team to Develop Powerful HIV Antibody
Mar 28, 2017 DUKE GLOBAL HEALTH INSTITUTE (919) 681-7760 globalhealth.duke.edu 310 Trent Drive, Durham, NC 27710 Box 90519, Durham, NC 27708See details»
Alberto Bartesaghi and Research Team Awarded Federal Grant to …
Sep 8, 2022 Duke CS and Biochemistry Associate Professor Alberto Bartesaghi and a research team including partners from the Duke Human Vaccine Institute (DHVI) received a federal …See details»
Science and Accountability | Duke Human Vaccine Institute - Duke …
Duke Human Vaccine Institute Science Culture and Accountability Plan. June 2024. The Mission of the Duke Human Vaccine Institute (DHVI) is to perform basic, translational and clinical …See details»
Duke Human Vaccine Institute Receives Industry Honor
Apr 30, 2013 The Duke Human Vaccine Institute (DHVI) recently won a Vaccine Industry Excellence Award for best academic research team. The honor, one of 13 awarded by the …See details»
Duke Center for HIV Structural Biology
The Duke Center for HIV Structural Biology (DCHSB) provides new insights into dynamics of HIV-1 entry and fusion with the host membrane, the Env-initiated immune activation of B cell …See details»